Close



Apr 10, 2024 07:30AM
Apr 8, 2024 04:30PM
Mar 28, 2024 07:30AM
Mar 22, 2024 09:37AM
Mar 22, 2024 09:36AM
Mar 21, 2024 07:31AM
Mar 21, 2024 07:30AM Theratechnologies Initiates Increased Dose Level in Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
Feb 27, 2024 07:30AM
Feb 27, 2024 07:30AM
Feb 21, 2024 07:30AM
Feb 20, 2024 07:32AM
Feb 20, 2024 07:30AM
Feb 15, 2024 07:30AM
Feb 6, 2024 07:30AM Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
Jan 24, 2024 07:05AM
Jan 24, 2024 07:00AM
Jan 23, 2024 07:33AM
Jan 23, 2024 07:30AM
Jan 2, 2024 07:30AM
Jan 2, 2024 07:30AM
Dec 13, 2023 07:30AM Theratechnologies (THTX) Announces FDA Approval of Trogarzo
Dec 13, 2023 07:30AM
Nov 24, 2023 07:30AM
Oct 19, 2023 07:31AM
Oct 19, 2023 07:30AM
Oct 13, 2023 07:30AM
Oct 13, 2023 07:01AM
Oct 13, 2023 07:00AM Theratechnologies Announces Results from Trogarzo® (Ibalizumab-uiyk) Intramuscular Administration Study
Oct 12, 2023 07:30AM
Oct 4, 2023 07:31AM
Oct 4, 2023 07:30AM
Sep 26, 2023 07:30AM
Sep 25, 2023 07:30AM
Sep 25, 2023 07:00AM
Aug 30, 2023 10:34AM Theratechnologies Announces All U.S. Oncology Clinical Sites Now Enrolling for Phase 1 Trial of Sudocetaxel Zendusortide
Jul 12, 2023 07:30AM
Jun 12, 2023 07:30AM
Jun 12, 2023 07:30AM
Jun 2, 2023 12:15PM
May 25, 2023 05:31PM
May 9, 2023 12:01PM
May 4, 2023 07:32AM Theratechnologies' (THTX) Trogarzo Shortens Time to HIV Undetectability and Extends Durability of Undetectability and Viral Suppression in a Matched Treatment Comparison
May 4, 2023 07:30AM
Apr 18, 2023 09:00AM
Apr 18, 2023 09:00AM
Apr 12, 2023 07:32AM
Apr 12, 2023 07:30AM
Apr 12, 2023 07:30AM
Mar 14, 2023 06:42PM Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
Mar 14, 2023 06:42PM

251,254 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All